AroCell has been recognized as “one of the companies with the most innovative ideas in the world” by the EU Commission and the Horizon 2020 Program Committee. “
We are delighted and honored that we have received this recognition and the €50.000 grant for a phase 1 project, especially as only 7% of the applications were accepted” says Jan Stålemark, CEO at AroCell.
“We scored 13.75 of 15 possible points with an average of 4.6 per criteria. The threshold for this call was 13.00, which is one of the highest ever noted for this program. In being awarded this grant, the uniqueness of our product
TK 210 ELISA is confirmed as well as the significant clinical need which is addressed by it.”
For additional information please contact:
Jan Stålemark, CEO
AroCell AB (publ)
Tel:+46 706 926206